̽»¨¾«Ñ¡

My research group focuses on the development of theranostics, i.e. radiopharmaceuticals for precision diagnostics, therapy and monitoring of diseases, with the emphasis in oncological diseases. We conduct studies to identify new targets and screen for new drugs for cancer treatments. In parallel, we perform novel developments of non-conventional radiometals using solid target on cyclotron, novel radiotracer developments, and biological evaluation studies in vitro and in vivo to clinical translation.

We are a multidisciplinary team consisting of pharmacists, radiochemists, medicine doctoral students, ̽»¨¾«Ñ¡ physicists and biologists. We collaborate closely and broadly with other research groups for generating drug screening, target identification, and clinicians, oncologists, and radiologists for clinical translation.